HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

EC145

has significant antiproliferative activity and tolerability, thus lending support to an ongoing phase 1 trial for the treatment of advanced malignancies
Networked: 15 relevant articles (2 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Leamon, Christopher P: 9 articles (10/2014 - 05/2007)
2. Reddy, Joseph A: 6 articles (10/2014 - 05/2007)
3. Vetzel, Marilynn: 5 articles (04/2014 - 05/2007)
4. Messmann, Richard A: 5 articles (12/2013 - 12/2009)
5. Dorton, Ryan: 4 articles (04/2014 - 05/2007)
6. Sausville, Edward A: 4 articles (12/2013 - 12/2009)
7. Klein, Patrick J: 4 articles (11/2012 - 09/2009)
8. Vlahov, Iontcho R: 4 articles (02/2011 - 05/2007)
9. Westrick, Elaine: 4 articles (02/2011 - 05/2007)
10. Edelman, Martin J: 3 articles (11/2012 - 05/2012)

Related Diseases

1. Neoplasms (Cancer)
2. Ovarian Neoplasms (Ovarian Cancer)
3. Constipation
4. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
5. Adenocarcinoma

Related Drugs and Biologics

1. Folic Acid (Vitamin M)
2. Platinum
3. Adenocarcinoma of lung
4. Ovarian epithelial cancer
5. pegylated liposomal doxorubicin
6. 1-dodecylpyridoxal (PLD)

Related Therapies and Procedures

1. Intravenous Injections
2. Drug Therapy (Chemotherapy)
3. Heterologous Transplantation (Xenotransplantation)
4. Therapeutics